Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Elissa Ozanne, PhD

    TitleAssociate Professor in Residence
    SchoolUCSF School of Medicine
    DepartmentSurgery
    Address3333 Calif. St,Laurel Heights
    San Francisco CA 94143
    Phone415-476-1942

       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Esserman L, Ozanne E, Van't Veer L. Will early detection for breast cancer ever work? Clin Chem. 2013 Jan; 59(1):190-3.
        View in: PubMed
      2. Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes KS. Which Risk Model to Use? Clinical Implications of the ACS MRI Screening Guidelines. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):146-9.
        View in: PubMed
      3. Ozanne EM, O'Connell A, Bouzan C, Bosinoff P, Rourke T, Dowd D, Drohan B, Millham F, Griffin P, Halpern EF, Semine A, Hughes KS. Bias in the reporting of family history: implications for clinical care. J Genet Couns. 2012 Aug; 21(4):547-56.
        View in: PubMed
      4. Campbell S, Stowe K, Ozanne EM. Interprofessional practice and decision support: an organizational framework applied to a mental health setting. J Interprof Care. 2011 Nov; 25(6):423-7.
        View in: PubMed
      5. Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 2012 Apr 15; 118(8):2021-30.
        View in: PubMed
      6. Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011 Sep; 129(2):607-16.
        View in: PubMed
      7. Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011 Aug; 129(1):165-73.
        View in: PubMed
      8. Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 2010 Mar; 254(3):793-800.
        View in: PubMed
      9. Ozanne EM, Wittenberg E, Garber JE, Weeks JC. Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J. 2010 Jan-Feb; 16(1):38-47.
        View in: PubMed
      10. Drohan B, Ozanne EM, Hughes KS. Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J. 2009 Sep-Oct; 15 Suppl 1:S46-55.
        View in: PubMed
      11. Sepucha K, Ozanne EM. How to define and measure concordance between patients' preferences and medical treatments: A systematic review of approaches and recommendations for standardization. Patient Educ Couns. 2010 Jan; 78(1):12-23.
        View in: PubMed
      12. Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR. Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53.
        View in: PubMed
      13. Sepucha KR, Ozanne EM, Partridge AH, Moy B. Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82.
        View in: PubMed
      14. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 1; 124(5):1213-9.
        View in: PubMed
      15. Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J. 2009 Mar-Apr; 15(2):155-62.
        View in: PubMed
      16. Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle GS. Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci. 2009 Oct; 54(10):2207-14.
        View in: PubMed
      17. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9.
        View in: PubMed
      18. Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol. 2008 Nov; 191(5):1308-19.
        View in: PubMed
      19. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2008 Oct; 103(10):2432-42.
        View in: PubMed
      20. Silvia KA, Ozanne EM, Sepucha KR. Implementing breast cancer decision aids in community sites: barriers and resources. Health Expect. 2008 Mar; 11(1):46-53.
        View in: PubMed
      21. Esserman LJ, Shieh Y, Park JW, Ozanne EM. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn. 2007 Sep; 7(5):533-44.
        View in: PubMed
      22. Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L. Pilot trial of a computerized decision aid for breast cancer prevention. Breast J. 2007 Mar-Apr; 13(2):147-54.
        View in: PubMed
      23. Sepucha K, Ozanne E, Mulley AG. Doing the right thing: systems support for decision quality in cancer care. Ann Behav Med. 2006 Dec; 32(3):172-8.
        View in: PubMed
      24. Sepucha K, Ozanne E, Silvia K, Partridge A, Mulley AG. An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007 Feb; 65(2):261-9.
        View in: PubMed
      25. Ozanne EM, Klemp JR, Esserman LJ. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J. 2006 Mar-Apr; 12(2):103-13.
        View in: PubMed
      26. Esserman LJ, Ozanne EM, Dowsett M, Slingerland JM. Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis. Breast Cancer Res. 2005; 7(6):R1153-8.
        View in: PubMed
      27. Ozanne EM, Esserman LJ. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):2043-52.
        View in: PubMed
      28. Esserman L, Sepucha K, Ozanne E, Hwang ES. Applying the neoadjuvant paradigm to ductal carcinoma in situ. Ann Surg Oncol. 2004 Jan; 11(1 Suppl):28S-36S.
        View in: PubMed
      29. Holtzman S, Ozanne E, Carone B, Goldstein MK, Steinke G, Timbs J. Decision analysis and Alzheimer disease: three case studies. Genet Test. 1999; 3(1):71-83.
        View in: PubMed
      Elissa's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (170) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (6) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP